Yeah, I agree. I too have found issues acquiring an optimal concentration of a given active in an extract, but in the case of Brassaiopsis, I already know that a properly extracted form exists. And it certainly is not 10:1
.
I'm not even going to touch the dopamine issue because we all know where that will end up. I will say that I've furthered my personal knowledge in biochem quite a bit since then, and I still stand by my previous stance, if perhaps slightly less extreme (with respect to halflife, which I do not believe to be the only limiting factor).
I also do believe that co-administration with certain compounds, none of which are found in Pr-XT, can improve endpoint effects.